<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00566553</url>
  </required_header>
  <id_info>
    <org_study_id>06-009628</org_study_id>
    <nct_id>NCT00566553</nct_id>
  </id_info>
  <brief_title>The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women</brief_title>
  <official_title>The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The role of estrogens in the pathogenesis of breast cancer has been well documented. This has
      led to the development of &quot;Anti-Estrogens&quot; (selective estrogens receptor modulators and
      Aromatase Inhibitors), used for treatment and prevention of breast cancer. These agents,
      however, have significant side effects, which are not acceptable to many healthy high-risk
      women. There is preliminary evidence that grape seed extract acts as &quot;natural&quot; aromatase
      inhibitor (1). This study has the potential to quantify the effectiveness of a natural
      substance that mimics the action of pharmaceutical aromatase inhibitors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early detection of breast cancer with screening mammography and the use of more effective
      medical therapies have led to a decrease in breast cancer mortality. However, breast cancer
      is still the second leading cause of cancer death in women (2). Therefore, the future lies in
      not only early detection but prevention of breast cancer. Currently available chemopreventive
      agents are associated with potentially serious side effects and can be quite costly,
      especially when taken for extended periods of time. Therefore, they are usually targeted only
      to women at high risk of disease. Identification of an inexpensive, efficacious preventive
      therapy with few or no side effects would represent a major advance in reducing the morbidity
      and mortality due to breast cancer. One exciting possibility is grape seed extract. Grapes
      and grape seeds contain procyanidins, a highly active subclass of flavonoids with actions
      similar to pharmaceutical aromatase inhibitors (AIs). These procyanidin dimers have been
      found to suppress estrogen biosynthesis both in vitro and in animal models (1). Based upon
      this knowledge we proposed this dose finding pilot study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To document that grape seed extract taken orally will decrease plasma estrogen levels (estrone (E1), estradiol (E2), and E1-conjugates) and increase precursor androgen levels (testosterone and androstenedione) in healthy postmenopausal women.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the most effective, well tolerated dose of grape seed extract resulting in a decrease in plasma estrogen levels (E1, E2, E1-conjugates) and increase in precursor androgens (testosterone and androstenedione).</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Grape Seed Extract # 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg [1 pill]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grape Seed Extract # 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg [2 pills]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grape Seed Extract # 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg [3 pills]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Grape Seed Extract # 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg [4 pills]</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grape Seed Extract</intervention_name>
    <description>200 mg dose daily for 12 weeks.</description>
    <arm_group_label>Grape Seed Extract # 1</arm_group_label>
    <other_name>ActiVin速</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grape Seed Extract</intervention_name>
    <description>400 mg dose daily for 12 weeks.</description>
    <arm_group_label>Grape Seed Extract # 2</arm_group_label>
    <other_name>ActiVin速</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grape Seed Extract</intervention_name>
    <description>600 mg dose daily for 12 weeks.</description>
    <arm_group_label>Grape Seed Extract # 3</arm_group_label>
    <other_name>ActiVin速</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grape Seed Extract</intervention_name>
    <description>800 mg dose daily for 12 weeks.</description>
    <arm_group_label>Grape Seed Extract # 4</arm_group_label>
    <other_name>ActiVin速</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 55 - 75 years

          -  Able to understand and sign a consent form

          -  Postmenopausal (no menstrual period for 1 year or more)

          -  No personal cancer history (except for non-melanoma skin cancer)

          -  No hormone replacement therapy or anti-estrogens within 6 months of baseline

        Exclusion Criteria:

          -  Known allergy to grapes or grape products

          -  Currently on ACE inhibitors, methotrexate, allopurinol, coumadin (Warfarin, Jantoven),
             heparin, clopidogrel (Plavix), or cholesterol lowering medication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dietlind L. Wahner-Roedler, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cancer.org/acs/groups/content/@nho/documents/document/caff2005f4pwsecuredpdf.pdf</url>
    <description>American Cancer Society. Cancer Facts &amp; Figures 2005.</description>
  </link>
  <reference>
    <citation>Eng ET, Ye J, Williams D, Phung S, Moore RE, Young MK, Gruntmanis U, Braunstein G, Chen S. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res. 2003 Dec 1;63(23):8516-22.</citation>
    <PMID>14679019</PMID>
  </reference>
  <reference>
    <citation>American Cancer Society. Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society; 2005.</citation>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2007</study_first_submitted>
  <study_first_submitted_qc>November 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2007</study_first_posted>
  <last_update_submitted>January 4, 2012</last_update_submitted>
  <last_update_submitted_qc>January 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Dietlind Wahner-Roedler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Grape Seed Extract</keyword>
  <keyword>Breast Cancer</keyword>
  <keyword>Estrogen Levels</keyword>
  <keyword>Aromatase Inhibitor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
    <mesh_term>Grape Seed Extract</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

